Periprosthetic Joint Infections of the Knee Lastingly Impact the Bone Homeostasis.

BIOCHEMICAL MARKERS OF BONE TURNOVER BONE μCT IMPLANTS OSTEOBLASTS OSTEOCLASTS PERIPROSTHETIC JOINT INFECTION REVISION ARTHROPLASTY

Journal

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: United States
ID NLM: 8610640

Informations de publication

Date de publication:
Oct 2023
Historique:
revised: 26 07 2023
received: 04 05 2023
accepted: 01 08 2023
pubmed: 3 8 2023
medline: 3 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

After periprosthetic joint infection (PJI)-dependent revision surgery, a significantly elevated number of patients suffer from prosthesis failure due to aseptic loosening and require additional revision surgery despite clearance of the initial infection. The mechanisms underlying this pathology are not well understood, as it has been assumed that the bone stock recovers after revision surgery. Despite clinical evidence suggesting decreased osteogenic potential in PJI, understanding of the underlying biology remains limited. In this study, we investigated the impact of PJI on bone homeostasis in a two-stage exchange approach at explantation and reimplantation. Sixty-four human tibial and femoral specimens (20 control, 20 PJI septic explantation, and 24 PJI prosthesis reimplantation samples) were analyzed for their bone microstructure, cellular composition, and expression of relevant genetic markers. Samples were analyzed using X-ray microtomography, Alcian blue and tartrate-resistant acid phosphatase staining, and RT-qPCR. In patients with PJI, bone volume (BV/TV; 0.173 ± 0.026; p < 0.001), trabecular thickness (164.262 ± 18.841 μm; p < 0.001), and bone mineral density (0.824 ± 0.017 g/cm

Identifiants

pubmed: 37534610
doi: 10.1002/jbmr.4892
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1472-1479

Subventions

Organisme : Berlin Institute of Health
Organisme : Deutschen Arthrose-Hilfe
ID : P482
Organisme : Charite Universitatsmedizin Berlin

Informations de copyright

© 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

Références

Kienzle A, Walter S, Palmowski Y, et al. Influence of gender on occurrence of aseptic loosening and recurrent PJI after revision total knee arthroplasty. Osteology. 2021;1(2):92-104.
Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA. Current epidemiology of revision total knee arthroplasty in the United States. J Arthroplasty. 2017;32(9):2663-2668.
Urquhart DM, Hanna FS, Brennan SL, et al. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty. 2010;25(8):1216-1222.e1-3.
Kienzle A, Walter S, von Roth P, Fuchs M, Winkler T, Muller M. High rates of aseptic loosening after revision total knee arthroplasty for periprosthetic joint infection. JB JS Open Access. 2020;5(3):e20.00026.
Crotti TN, Dharmapatni AA, Alias E, Haynes DR. Osteoimmunology: major and costimulatory pathway expression associated with chronic inflammatory induced bone loss. J Immunol Res. 2015;2015:281287.
Ren Y, Backer H, Muller M, Kienzle A. The role of myeloid derived suppressor cells in musculoskeletal disorders. Front Immunol. 2023;14:1139683.
Biedermann L, Bandick E, Ren Y, et al. Inflammation of bone in patients with periprosthetic joint infections of the knee. JB JS Open Access. 2023;8(1):e22.00101.
Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko Camacho N, Bostrom MP. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone. 2007;41(6):928-936.
Horwood NJ, Elliott J, Martin TJ, Gillespie MT. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol. 2001;166(8):4915-4921.
Mountziaris PM, Spicer PP, Kasper FK, Mikos AG. Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev. 2011;17(6):393-402.
Lienau J, Schmidt-Bleek K, Peters A, et al. Differential regulation of blood vessel formation between standard and delayed bone healing. J Orthop Res. 2009;27(9):1133-1140.
Schmidt-Bleek K, Schell H, Schulz N, et al. Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res. 2012;347(3):567-573.
Ormsby RT, Zelmer AR, Yang D, et al. Evidence for osteocyte-mediated bone-matrix degradation associated with periprosthetic joint infection (PJI). Eur Cell Mater. 2021;42:264-280.
Lehmann W, Edgar CM, Wang K, et al. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone. 2005;36(2):300-310.
McNally M, Sousa R, Wouthuyzen-Bakker M, et al. The EBJIS definition of periprosthetic joint infection. Bone Joint J. 2021;103-B(1):18-25.
Murahashi Y, Teramoto A, Jimbo S, et al. Denosumab prevents periprosthetic bone mineral density loss in the tibial metaphysis in total knee arthroplasty. Knee. 2020;27(2):580-586.
Butscheidt S, Hinz N, Hubert J, Beil FT, Rolvien T. Lokale Aktivierung des Knochenstoffwechsels bei periprothetischen Infektionen Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2022); Berlin; 2022.
Li C, Li G, Liu M, Zhou T, Zhou H. Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function. J Biosci Bioeng. 2016;121(2):213-219.
Liu J, Chen B, Yan F, Yang W. The influence of inflammatory cytokines on the proliferation and osteoblastic differentiation of MSCs. Curr Stem Cell Res Ther. 2017;12(5):401-408.
Liu X, He W, Fang Z, Kienzle A, Feng Q. Influence of silver nanoparticles on osteogenic differentiation of human mesenchymal stem cells. J Biomed Nanotechnol. 2014;10(7):1277-1285.
Day AJ, Milner CM. TSG-6: a multifunctional protein with anti-inflammatory and tissue-protective properties. Matrix Biol. 2019;78-79:60-83.
Stambough JB, Curtin BM, Odum SM, Cross MB, Martin JR, Fehring TK. Does change in ESR and CRP guide the timing of two-stage arthroplasty reimplantation? Clin Orthop Relat Res. 2019;477(2):364-371.

Auteurs

Evgeniya Bandick (E)

Center for Musculoskeletal Surgery, Clinic for Orthopedics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Lara Biedermann (L)

Center for Musculoskeletal Surgery, Clinic for Orthopedics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Yi Ren (Y)

Center for Musculoskeletal Surgery, Clinic for Orthopedics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Stefanie Donner (S)

Center for Musculoskeletal Surgery, Clinic for Orthopedics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Mario Thiele (M)

Julius Wolff Institute and Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Gabriela Korus (G)

Julius Wolff Institute and Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Serafeim Tsitsilonis (S)

Center for Musculoskeletal Surgery, Clinic for Orthopedics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Michael Müller (M)

Center for Musculoskeletal Surgery, Clinic for Orthopedics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Georg Duda (G)

Julius Wolff Institute and Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Carsten Perka (C)

Center for Musculoskeletal Surgery, Clinic for Orthopedics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Arne Kienzle (A)

Center for Musculoskeletal Surgery, Clinic for Orthopedics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Julius Wolff Institute and Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.

Classifications MeSH